Best Appetite Suppressant Peptides: Mechanisms and Evidence

Which peptides actually suppress appetite and by what mechanism — GLP-1s by far the leaders, plus amylin analogs (cagrilintide), and the weaker evidence for GH secretagogues and AOD-9604.

GLP-1s Own the Category

Appetite suppression is the GLP-1 mechanism in one sentence: receptor agonism in the hypothalamic appetite centers plus slowed gastric emptying equals reduced food intake, and the trial data is the strongest in all of metabolic pharmacotherapy. Semaglutide (STEP-1: ~15% weight loss), tirzepatide (SURMOUNT-1: 22.5%), and retatrutide (TRIUMPH-4: up to 31% mean loss) form the efficacy ladder, with liraglutide as the daily-dosed short-acting option. Retatrutide's triple-agonist design (GLP-1 + GIP + glucagon) adds an energy-expenditure component the others lack — the reason its trial numbers lead the class even though it remains investigational in 2026. Every one of these has a titration calculator in our tools section.

Amylin: The Satiety Partner Mechanism

Cagrilintide is the amylin analog bringing a second satiety pathway to research protocols — amylin is co-secreted with insulin and acts on appetite and gastric emptying through receptors distinct from GLP-1, which is why the combination (cagrisema: cagrilintide + semaglutide) is one of the most-watched candidates in the pipeline. In trials, cagrilintide showed dose-dependent weight loss up to 4.5 mg weekly, and combination data suggested additive effects. For appetite-focused research, amylin agonism is the most important post-GLP-1 mechanism. Our cagrilintide chart covers the weekly research ranges; our cagrisema article covers the combination evidence.

The Weaker Claims: GH Peptides and AOD-9604

Two categories get marketed for appetite effects with thin support. GH secretagogues (MK-677, CJC-1295) can increase appetite in many users — the opposite of the claimed direction — because ghrelin-mimetic signaling is orexigenic; if anything, this argues against them for appetite suppression. AOD-9604, the lipolytic fragment of growth hormone, is marketed for fat loss but the human RCTs on weight loss were unimpressive, and appetite suppression was never its mechanism. The honest list of appetite suppressants with evidence: the GLP-1 family, amylin analogs — and nothing else in the current peptide space approaches their trial support. Semaglutide shortage-era compounding made "generic" appetite suppressants widely available; the shortage has ended and the FDA has been closing that window, which our news coverage tracks.

Using the Calculators for Satiety Research Protocols

For protocol math on appetite-focused compounds: the GLP-1 calculators encode the clinical titration ladders (weekly escalation steps with maintenance targets), the cagrilintide chart covers the weekly dosing range from 0.3 mg initiation to 4.5 mg upper trial range, and the peptide-stack calculator checks combined-dose math for anyone researching combination protocols. All appetite peptides remain research compounds or prescription drugs depending on jurisdiction and compound — the approved ones route through physicians, and the investigational ones (retatrutide, cagrisema, cagrilintide) have no approved dosing. The appetite mechanism is also the mechanism of the counterfeit problem: demand for GLP-1s makes them the most counterfeited drug category, which is why our vendor guides and COA verification exist.

📊 Dosage Calculator & Protocol Chart

Use our free Appetite Peptides dosage calculator to plan your protocol:

👉 Appetite Peptides Dosage Calculator — Calculate exact dosing, reconstitution ratios, and injection volumes.

👉 Full Dosing Guide & Protocol Chart — Complete protocol with weekly titration schedule, side effect management, and cycle recommendations.

Important Disclaimer

This article is for educational and research purposes only. Peptides discussed may not be FDA-approved for all uses described. Always consult with a qualified healthcare provider before starting any peptide protocol. The information provided here is synthesized from published research, clinical trial data, and community discussions.

Keywords: best appetite suppressant peptide, appetite suppressant peptides, cagrilintide appetite, glp-1 appetite suppression, amylin peptide

Sources: Published research papers, clinical trial databases, community discussions, peptiq.io educational content